β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis

被引:0
作者
Tianyu Xu
Yuli Huang
Haobin Zhou
Yujia Bai
Xingfu Huang
Yunzhao Hu
Dingli Xu
Yuhui Zhang
Jian Zhang
机构
[1] State Key Laboratory of Cardiovascular Disease,Department of Cardiology
[2] Heart Failure Center,State Key Laboratory of Organ Failure Research, Department of Cardiology
[3] Fuwai Hospital,undefined
[4] National Center for Cardiovascular Diseases,undefined
[5] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[6] Shunde Hospital,undefined
[7] Southern Medical University,undefined
[8] Nanfang Hospital,undefined
[9] Southern Medical University,undefined
来源
BMC Cardiovascular Disorders | / 19卷
关键词
Heart failure; Atrial fibrillation; Beta blockers; All-cause mortality;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 318 条
  • [1] Braunwald E(2015)The war against heart failure: the Lancet lecture Lancet 385 812-824
  • [2] Mozaffarian D(2015)Heart disease and stroke statistics--2015 update: a report from the American Heart Association Circulation 131 e29-e322
  • [3] Benjamin EJ(2010)Long-term survival of cancer patients compared to heart failure and stroke: a systematic review BMC Cancer 10 105-2200
  • [4] Go AS(2016)2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC Eur Heart J 37 2129-135
  • [5] Arnett DK(2015)Atrial fibrillation and heart failure: update 2015 Prog Cardiovasc Dis 58 126-56
  • [6] Blaha MJ(2009)Pathophysiology of concomitant atrial fibrillation and heart failure: implications for management Nat Clin Pract Cardiovasc Med 6 46-8D
  • [7] Cushman M(2003)Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy Am J Cardiol 91 2D-787
  • [8] de Ferranti S(2014)Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-preserve) Eur J Heart Fail 16 778-2243
  • [9] Despres JP(2014)Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis Lancet 384 2235-28
  • [10] Fullerton HJ(2013)Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis JACC Heart Fail 1 21-e239